Another point to consider is MYD88 mutation, and lymphocytic flow‐cytometric markers can become positive in other lymphoproliferative disorders, like marginal zone lymphoma (MZL) or chronic lymphocytic leukemia (CLL).8, 9. This evidence concerns the gene MYD88 and B-cell chronic lymphocytic leukemia.